1. In-vitro and in-vivo antibacterial activity of T-3912, a novel non-fluorinated topical quinolone;Yamakawa;J. Anitimicorb. Chemother.,2002
2. Solubility principles and practices for parenteral drug dosage form development;Sweetana;PDA J. Pharm. Sci. Technol.,1996
3. Excipients and their use in injectable products;Nema;PDA J. Pharm. Sci. Technol.,1997
4. Increasing solubility of enoxacin and norfloxacin by means of salt formation;Spurlock;J. Parent. Sci. Technol.,1986
5. Physicochemical characterization and dissolution of norfloxacin/cyclodextrin inclusion compounds and PEG solid dispersions;Guyot;Int. J. Pharm.,1995